HEADER IMMUNE SYSTEM 07-MAR-10 2X89 TITLE STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIBODY; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: D, E, F, G; COMPND 8 FRAGMENT: RESIDUES 27-119; COMPND 9 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMELUS DROMEDARIUS; SOURCE 3 ORGANISM_COMMON: ARABIAN CAMEL; SOURCE 4 ORGANISM_TAXID: 9838; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR K.DOMANSKA,V.SRINIVASAN,S.VANDERHAEGEN,E.PARDON,J.A.MARQUEZ, AUTHOR 2 V.BELLOTTI,L.WYNS,J.STEYAERT REVDAT 4 20-DEC-23 2X89 1 REMARK REVDAT 3 04-SEP-13 2X89 1 SOURCE REMARK VERSN LINK REVDAT 2 16-FEB-11 2X89 1 JRNL REMARK REVDAT 1 19-JAN-11 2X89 0 JRNL AUTH K.DOMANSKA,S.VANDERHAEGEN,V.SRINIVASAN,E.PARDON,F.DUPEUX, JRNL AUTH 2 J.A.MARQUEZ,S.GIORGETTI,M.STOPPINI,L.WYNS,V.BELLOTTI, JRNL AUTH 3 J.STEYAERT JRNL TITL ATOMIC STRUCTURE OF A NANOBODY-TRAPPED DOMAIN-SWAPPED DIMER JRNL TITL 2 OF AN AMYLOIDOGENIC {BETA}2-MICROGLOBULIN VARIANT. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 1314 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21220305 JRNL DOI 10.1073/PNAS.1008560108 REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 62741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3356 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.16 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.22 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4562 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2690 REMARK 3 BIN FREE R VALUE SET COUNT : 216 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5930 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 295 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.07000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.215 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.186 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.132 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.727 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6078 ; 0.028 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8226 ; 2.439 ; 1.933 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 735 ; 9.840 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 309 ;38.271 ;23.625 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 985 ;18.965 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;21.780 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 853 ; 0.187 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4722 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2794 ; 0.282 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3956 ; 0.318 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 414 ; 0.223 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 87 ; 0.290 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3792 ; 1.482 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5899 ; 2.269 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2702 ; 3.678 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2327 ; 5.596 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 95 A 220 4 REMARK 3 1 B 95 B 220 4 REMARK 3 1 C 95 C 220 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 974 ; 0.43 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 974 ; 0.61 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 C (A): 974 ; 0.41 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 974 ; 2.23 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 974 ; 2.09 ; 2.00 REMARK 3 MEDIUM THERMAL 1 C (A**2): 974 ; 2.27 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : D E F G REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 D 1 D 92 4 REMARK 3 1 E 1 E 92 4 REMARK 3 1 F 1 F 92 4 REMARK 3 1 G 1 G 92 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 D (A): 672 ; 1.32 ; 0.50 REMARK 3 MEDIUM POSITIONAL 2 E (A): 672 ; 1.51 ; 0.50 REMARK 3 MEDIUM POSITIONAL 2 F (A): 672 ; 1.19 ; 0.50 REMARK 3 MEDIUM POSITIONAL 2 G (A): 672 ; 1.37 ; 0.50 REMARK 3 MEDIUM THERMAL 2 D (A**2): 672 ; 1.97 ; 2.00 REMARK 3 MEDIUM THERMAL 2 E (A**2): 672 ; 2.08 ; 2.00 REMARK 3 MEDIUM THERMAL 2 F (A**2): 672 ; 2.21 ; 2.00 REMARK 3 MEDIUM THERMAL 2 G (A**2): 672 ; 2.23 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 7 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 128 REMARK 3 ORIGIN FOR THE GROUP (A): -67.8247 18.3046 6.6027 REMARK 3 T TENSOR REMARK 3 T11: -0.2350 T22: -0.2469 REMARK 3 T33: -0.2336 T12: 0.0091 REMARK 3 T13: 0.0082 T23: -0.0029 REMARK 3 L TENSOR REMARK 3 L11: 4.0279 L22: 2.5568 REMARK 3 L33: 1.9727 L12: 1.0529 REMARK 3 L13: -1.2964 L23: -0.8182 REMARK 3 S TENSOR REMARK 3 S11: 0.1351 S12: 0.1223 S13: 0.3975 REMARK 3 S21: -0.1184 S22: -0.0401 S23: 0.1939 REMARK 3 S31: -0.1895 S32: -0.2109 S33: -0.0950 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 128 REMARK 3 ORIGIN FOR THE GROUP (A): -33.1805 -5.2654 19.2975 REMARK 3 T TENSOR REMARK 3 T11: -0.3128 T22: -0.3256 REMARK 3 T33: -0.3015 T12: 0.0094 REMARK 3 T13: -0.0055 T23: -0.0193 REMARK 3 L TENSOR REMARK 3 L11: 3.1111 L22: 3.3466 REMARK 3 L33: 3.7538 L12: 0.6746 REMARK 3 L13: -1.4072 L23: -2.2265 REMARK 3 S TENSOR REMARK 3 S11: 0.0267 S12: 0.2415 S13: -0.0600 REMARK 3 S21: -0.0413 S22: 0.0477 S23: 0.0863 REMARK 3 S31: 0.2038 S32: -0.2467 S33: -0.0743 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 128 REMARK 3 ORIGIN FOR THE GROUP (A): -32.3367 2.5009 -44.2155 REMARK 3 T TENSOR REMARK 3 T11: -0.2486 T22: -0.3275 REMARK 3 T33: -0.2599 T12: 0.0253 REMARK 3 T13: 0.0349 T23: 0.0131 REMARK 3 L TENSOR REMARK 3 L11: 2.5541 L22: 1.5914 REMARK 3 L33: 5.9706 L12: -0.1196 REMARK 3 L13: 1.0626 L23: 0.2278 REMARK 3 S TENSOR REMARK 3 S11: 0.0276 S12: -0.0349 S13: -0.3027 REMARK 3 S21: -0.0359 S22: 0.0610 S23: 0.0354 REMARK 3 S31: 0.5604 S32: -0.0167 S33: -0.0886 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 6 D 97 REMARK 3 ORIGIN FOR THE GROUP (A): -40.7070 13.4972 -4.8917 REMARK 3 T TENSOR REMARK 3 T11: -0.2763 T22: -0.1574 REMARK 3 T33: -0.1379 T12: -0.0300 REMARK 3 T13: -0.0036 T23: 0.0347 REMARK 3 L TENSOR REMARK 3 L11: 1.2732 L22: 1.2346 REMARK 3 L33: 5.9368 L12: -0.3190 REMARK 3 L13: -0.6844 L23: -1.9559 REMARK 3 S TENSOR REMARK 3 S11: 0.0951 S12: -0.2161 S13: 0.0490 REMARK 3 S21: -0.0216 S22: -0.0187 S23: -0.2374 REMARK 3 S31: -0.0650 S32: 0.4987 S33: -0.0763 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 6 E 96 REMARK 3 ORIGIN FOR THE GROUP (A): -39.9340 20.8889 -22.2631 REMARK 3 T TENSOR REMARK 3 T11: -0.1964 T22: -0.2662 REMARK 3 T33: -0.2359 T12: 0.0078 REMARK 3 T13: 0.0093 T23: -0.0440 REMARK 3 L TENSOR REMARK 3 L11: 0.3420 L22: 1.5650 REMARK 3 L33: 3.7796 L12: 0.0119 REMARK 3 L13: -0.6062 L23: -1.1947 REMARK 3 S TENSOR REMARK 3 S11: 0.1249 S12: -0.1488 S13: 0.1688 REMARK 3 S21: 0.0504 S22: 0.0681 S23: 0.0521 REMARK 3 S31: -0.1192 S32: 0.0901 S33: -0.1930 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 6 F 96 REMARK 3 ORIGIN FOR THE GROUP (A): -11.3838 5.4925 2.3181 REMARK 3 T TENSOR REMARK 3 T11: -0.2208 T22: -0.2201 REMARK 3 T33: -0.2161 T12: -0.0091 REMARK 3 T13: 0.0160 T23: 0.0333 REMARK 3 L TENSOR REMARK 3 L11: 2.3197 L22: 1.6347 REMARK 3 L33: 4.2338 L12: 1.4266 REMARK 3 L13: -0.0309 L23: 0.3720 REMARK 3 S TENSOR REMARK 3 S11: -0.0253 S12: 0.3187 S13: 0.1339 REMARK 3 S21: -0.3254 S22: 0.2494 S23: -0.1578 REMARK 3 S31: -0.1617 S32: 0.3897 S33: -0.2241 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : G 6 G 97 REMARK 3 ORIGIN FOR THE GROUP (A): -14.0042 3.2311 -16.8882 REMARK 3 T TENSOR REMARK 3 T11: -0.1011 T22: -0.1261 REMARK 3 T33: -0.0751 T12: 0.0149 REMARK 3 T13: -0.0122 T23: 0.0518 REMARK 3 L TENSOR REMARK 3 L11: 1.0058 L22: 0.0615 REMARK 3 L33: 9.9405 L12: -0.0829 REMARK 3 L13: -0.0907 L23: 0.7446 REMARK 3 S TENSOR REMARK 3 S11: 0.1205 S12: 0.3062 S13: 0.2385 REMARK 3 S21: -0.0285 S22: 0.1114 S23: -0.0256 REMARK 3 S31: -0.6295 S32: -0.0463 S33: -0.2319 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ONE MOLECULE IN THE ASYMMETRIC UNIT IS DISORDERED. REMARK 4 REMARK 4 2X89 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290042956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97812 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66127 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1BMG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6%PEG4000, 0.2M AMMONIUM SULPHATE, REMARK 280 0.1M NA-ACETEATE PH4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.43200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP D 98 REMARK 465 MET D 99 REMARK 465 ARG E 97 REMARK 465 ASP E 98 REMARK 465 MET E 99 REMARK 465 ARG F 97 REMARK 465 ASP F 98 REMARK 465 MET F 99 REMARK 465 ALA G 15 REMARK 465 GLU G 16 REMARK 465 ASN G 17 REMARK 465 SER G 57 REMARK 465 LYS G 58 REMARK 465 ASP G 59 REMARK 465 ASP G 98 REMARK 465 MET G 99 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 117 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ALA D 15 CB REMARK 470 GLU D 16 CB CG CD OE1 OE2 REMARK 470 ASN D 17 CB CG OD1 ND2 REMARK 470 LYS D 19 CG CD CE NZ REMARK 470 SER E 57 CB OG REMARK 470 LYS E 58 CB CG CD CE NZ REMARK 470 ASP E 59 CB CG OD1 OD2 REMARK 470 TRP E 60 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP E 60 CZ3 CH2 REMARK 470 LYS G 19 CG CD CE NZ REMARK 470 SER G 20 OG REMARK 470 LEU G 40 CG CD1 CD2 REMARK 470 TRP G 60 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP G 60 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR C 117 O HOH C 2039 0.74 REMARK 500 CD1 TYR C 117 O HOH C 2041 0.84 REMARK 500 CE1 TYR C 117 O HOH C 2041 0.89 REMARK 500 CE2 TYR C 117 O HOH C 2040 0.89 REMARK 500 CD2 TYR C 117 O HOH C 2040 0.98 REMARK 500 CZ TYR C 117 O HOH C 2039 1.05 REMARK 500 CG TYR C 117 O HOH C 2041 1.53 REMARK 500 CZ TYR C 117 O HOH C 2041 1.56 REMARK 500 O HIS G 31 CB ASP G 34 1.57 REMARK 500 CE2 TYR C 117 O HOH C 2039 1.83 REMARK 500 OD1 ASP C 99 NH1 ARG C 103 1.98 REMARK 500 CD2 TYR C 117 O HOH C 2041 1.98 REMARK 500 CE2 TYR C 117 O HOH C 2041 2.00 REMARK 500 O ASP C 73 O ALA C 75 2.04 REMARK 500 OG SER G 11 O HIS G 13 2.10 REMARK 500 NH2 ARG C 103 NE2 GLN G 8 2.11 REMARK 500 CZ TYR C 117 O HOH C 2040 2.12 REMARK 500 OE1 GLN C 72 CG2 VAL C 79 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 22 CB CYS B 22 SG -0.107 REMARK 500 ARG B 55 C ASP B 56 N -0.169 REMARK 500 GLU B 87 CG GLU B 87 CD 0.091 REMARK 500 GLU B 89 CG GLU B 89 CD 0.101 REMARK 500 CYS B 96 CA CYS B 96 CB 0.135 REMARK 500 CYS B 104 CB CYS B 104 SG -0.101 REMARK 500 GLU C 89 CB GLU C 89 CG 0.153 REMARK 500 GLU C 89 CG GLU C 89 CD 0.114 REMARK 500 GLU C 89 CD GLU C 89 OE2 0.085 REMARK 500 CYS D 25 CB CYS D 25 SG -0.104 REMARK 500 CYS D 80 CB CYS D 80 SG -0.134 REMARK 500 GLU E 36 CG GLU E 36 CD 0.153 REMARK 500 GLU E 36 CD GLU E 36 OE1 0.076 REMARK 500 CYS E 80 CB CYS E 80 SG -0.105 REMARK 500 CYS F 80 CB CYS F 80 SG -0.139 REMARK 500 PHE G 30 N PHE G 30 CA 0.137 REMARK 500 TRP G 95 CE3 TRP G 95 CZ3 -0.146 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 38 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP A 56 CB - CG - OD1 ANGL. DEV. = 8.4 DEGREES REMARK 500 ASP B 56 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 GLN B 72 CB - CA - C ANGL. DEV. = -13.8 DEGREES REMARK 500 CYS B 96 CA - CB - SG ANGL. DEV. = -13.8 DEGREES REMARK 500 ARG C 19 CG - CD - NE ANGL. DEV. = 16.2 DEGREES REMARK 500 ASP C 29 CB - CG - OD1 ANGL. DEV. = -6.5 DEGREES REMARK 500 ARG C 45 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 LYS C 65 CD - CE - NZ ANGL. DEV. = -22.1 DEGREES REMARK 500 SER C 85 CB - CA - C ANGL. DEV. = 18.1 DEGREES REMARK 500 ARG C 103 NE - CZ - NH1 ANGL. DEV. = -5.2 DEGREES REMARK 500 MET D 6 CG - SD - CE ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG E 81 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG E 81 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ASP F 59 N - CA - C ANGL. DEV. = 16.3 DEGREES REMARK 500 ARG F 81 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG F 81 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 GLY G 29 N - CA - C ANGL. DEV. = 17.5 DEGREES REMARK 500 PHE G 30 N - CA - C ANGL. DEV. = 17.4 DEGREES REMARK 500 LEU G 64 CA - CB - CG ANGL. DEV. = 17.1 DEGREES REMARK 500 LEU G 64 CB - CG - CD2 ANGL. DEV. = -10.4 DEGREES REMARK 500 ARG G 81 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 29.78 43.96 REMARK 500 TYR A 32 139.49 -170.76 REMARK 500 LYS A 76 -1.70 -158.30 REMARK 500 ASN A 77 -12.53 76.79 REMARK 500 ALA A 92 173.36 177.81 REMARK 500 TYR B 32 141.56 -171.98 REMARK 500 GLN B 72 138.17 147.83 REMARK 500 ASN B 77 -43.15 74.68 REMARK 500 ALA B 92 166.88 174.98 REMARK 500 VAL B 108 135.41 -39.34 REMARK 500 ALA C 14 134.30 -35.23 REMARK 500 ASP C 29 44.73 32.08 REMARK 500 GLN C 72 -128.14 -154.49 REMARK 500 ASP C 73 148.68 124.58 REMARK 500 ALA C 75 -150.03 -75.03 REMARK 500 ASN C 77 -35.67 115.02 REMARK 500 ALA C 92 163.08 170.70 REMARK 500 ASN D 17 -1.57 102.69 REMARK 500 LYS D 19 -78.74 -99.22 REMARK 500 SER D 20 124.95 146.12 REMARK 500 LYS E 48 -47.28 -27.52 REMARK 500 SER E 57 98.99 -68.58 REMARK 500 LYS E 58 21.39 130.09 REMARK 500 ASN F 42 38.45 36.86 REMARK 500 SER F 57 22.30 83.55 REMARK 500 ASP F 59 -158.59 145.96 REMARK 500 TRP F 60 -9.64 70.78 REMARK 500 PRO G 32 -13.68 -47.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 74 ALA A 75 43.05 REMARK 500 ALA A 75 LYS A 76 93.65 REMARK 500 SER B 7 GLY B 8 -128.33 REMARK 500 SER B 71 GLN B 72 -130.89 REMARK 500 ALA B 75 LYS B 76 139.93 REMARK 500 LYS B 76 ASN B 77 -144.73 REMARK 500 LYS C 76 ASN C 77 -144.85 REMARK 500 GLY C 119 GLN C 120 143.18 REMARK 500 SER D 20 ASN D 21 -149.28 REMARK 500 LYS E 48 VAL E 49 -132.27 REMARK 500 LYS F 58 ASP F 59 149.36 REMARK 500 SER F 61 PHE F 62 -149.13 REMARK 500 HIS G 31 PRO G 32 -146.23 REMARK 500 SER G 33 ASP G 34 149.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2017 DISTANCE = 6.80 ANGSTROMS REMARK 525 HOH B2018 DISTANCE = 8.24 ANGSTROMS REMARK 525 HOH G2003 DISTANCE = 7.63 ANGSTROMS REMARK 525 HOH G2004 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH G2021 DISTANCE = 6.12 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 2XKS RELATED DB: PDB REMARK 900 PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 2VLK RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 2X4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 PEPTIDE REMARK 900 RT468-476 REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 2X4O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 ENVELOPE REMARK 900 PEPTIDE ENV120- 128 REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA- A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 2X4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A REMARK 900 PHOTOCLEAVABLE PEPTIDE REMARK 900 RELATED ID: 2VLR RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BVO RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 2XKU RELATED DB: PDB REMARK 900 PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 2J8U RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. REMARK 900 RELATED ID: 2XPG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 2X4T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEIODATE- REMARK 900 CLEAVABLE PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 2BVP RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2X4R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO CYTOMEGALOVIRUS REMARK 900 (CMV) PP65 EPITOPE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE ( RESIDUES 412-420) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2X70 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A REMARK 900 PHOTOCLEAVABLE PEPTIDE REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 2X4N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO RESIDUAL REMARK 900 FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT REMARK 900 TREATMENT REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 2VLL RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2VLJ RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 2X4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEPTIDE REMARK 900 REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. DBREF 2X89 A 1 128 PDB 2X89 2X89 1 128 DBREF 2X89 B 1 128 PDB 2X89 2X89 1 128 DBREF 2X89 C 1 128 PDB 2X89 2X89 1 128 DBREF 2X89 D 7 99 UNP P61769 B2MG_HUMAN 27 119 DBREF 2X89 E 7 99 UNP P61769 B2MG_HUMAN 27 119 DBREF 2X89 F 7 99 UNP P61769 B2MG_HUMAN 27 119 DBREF 2X89 G 7 99 UNP P61769 B2MG_HUMAN 27 119 SEQADV 2X89 MET D 6 UNP P61769 EXPRESSION TAG SEQADV 2X89 MET E 6 UNP P61769 EXPRESSION TAG SEQADV 2X89 MET F 6 UNP P61769 EXPRESSION TAG SEQADV 2X89 MET G 6 UNP P61769 EXPRESSION TAG SEQRES 1 A 128 GLN VAL GLN LEU GLN GLU SER GLY GLY GLY SER VAL GLN SEQRES 2 A 128 ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 A 128 TYR THR ASP SER ARG TYR CYS MET ALA TRP PHE ARG GLN SEQRES 4 A 128 ALA PRO GLY LYS GLU ARG GLU TRP VAL ALA ARG ILE ASN SEQRES 5 A 128 SER GLY ARG ASP ILE THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 A 128 GLY ARG PHE THR PHE SER GLN ASP ASN ALA LYS ASN THR SEQRES 7 A 128 VAL TYR LEU GLN MET ASP SER LEU GLU PRO GLU ASP THR SEQRES 8 A 128 ALA THR TYR TYR CYS ALA THR ASP ILE PRO LEU ARG CYS SEQRES 9 A 128 ARG ASP ILE VAL ALA LYS GLY GLY ASP GLY PHE ARG TYR SEQRES 10 A 128 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER SEQRES 1 B 128 GLN VAL GLN LEU GLN GLU SER GLY GLY GLY SER VAL GLN SEQRES 2 B 128 ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 128 TYR THR ASP SER ARG TYR CYS MET ALA TRP PHE ARG GLN SEQRES 4 B 128 ALA PRO GLY LYS GLU ARG GLU TRP VAL ALA ARG ILE ASN SEQRES 5 B 128 SER GLY ARG ASP ILE THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 B 128 GLY ARG PHE THR PHE SER GLN ASP ASN ALA LYS ASN THR SEQRES 7 B 128 VAL TYR LEU GLN MET ASP SER LEU GLU PRO GLU ASP THR SEQRES 8 B 128 ALA THR TYR TYR CYS ALA THR ASP ILE PRO LEU ARG CYS SEQRES 9 B 128 ARG ASP ILE VAL ALA LYS GLY GLY ASP GLY PHE ARG TYR SEQRES 10 B 128 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER SEQRES 1 C 128 GLN VAL GLN LEU GLN GLU SER GLY GLY GLY SER VAL GLN SEQRES 2 C 128 ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 C 128 TYR THR ASP SER ARG TYR CYS MET ALA TRP PHE ARG GLN SEQRES 4 C 128 ALA PRO GLY LYS GLU ARG GLU TRP VAL ALA ARG ILE ASN SEQRES 5 C 128 SER GLY ARG ASP ILE THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 C 128 GLY ARG PHE THR PHE SER GLN ASP ASN ALA LYS ASN THR SEQRES 7 C 128 VAL TYR LEU GLN MET ASP SER LEU GLU PRO GLU ASP THR SEQRES 8 C 128 ALA THR TYR TYR CYS ALA THR ASP ILE PRO LEU ARG CYS SEQRES 9 C 128 ARG ASP ILE VAL ALA LYS GLY GLY ASP GLY PHE ARG TYR SEQRES 10 C 128 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER SEQRES 1 D 94 MET ILE GLN VAL TYR SER ARG HIS PRO ALA GLU ASN GLY SEQRES 2 D 94 LYS SER ASN PHE LEU ASN CYS TYR VAL SER GLY PHE HIS SEQRES 3 D 94 PRO SER ASP ILE GLU VAL ASP LEU LEU LYS ASN GLY GLU SEQRES 4 D 94 ARG ILE GLU LYS VAL GLU HIS SER ASP LEU SER PHE SER SEQRES 5 D 94 LYS ASP TRP SER PHE TYR LEU LEU TYR TYR THR GLU PHE SEQRES 6 D 94 THR PRO THR GLU LYS ASP GLU TYR ALA CYS ARG VAL ASN SEQRES 7 D 94 HIS VAL THR LEU SER GLN PRO LYS ILE VAL LYS TRP ASP SEQRES 8 D 94 ARG ASP MET SEQRES 1 E 94 MET ILE GLN VAL TYR SER ARG HIS PRO ALA GLU ASN GLY SEQRES 2 E 94 LYS SER ASN PHE LEU ASN CYS TYR VAL SER GLY PHE HIS SEQRES 3 E 94 PRO SER ASP ILE GLU VAL ASP LEU LEU LYS ASN GLY GLU SEQRES 4 E 94 ARG ILE GLU LYS VAL GLU HIS SER ASP LEU SER PHE SER SEQRES 5 E 94 LYS ASP TRP SER PHE TYR LEU LEU TYR TYR THR GLU PHE SEQRES 6 E 94 THR PRO THR GLU LYS ASP GLU TYR ALA CYS ARG VAL ASN SEQRES 7 E 94 HIS VAL THR LEU SER GLN PRO LYS ILE VAL LYS TRP ASP SEQRES 8 E 94 ARG ASP MET SEQRES 1 F 94 MET ILE GLN VAL TYR SER ARG HIS PRO ALA GLU ASN GLY SEQRES 2 F 94 LYS SER ASN PHE LEU ASN CYS TYR VAL SER GLY PHE HIS SEQRES 3 F 94 PRO SER ASP ILE GLU VAL ASP LEU LEU LYS ASN GLY GLU SEQRES 4 F 94 ARG ILE GLU LYS VAL GLU HIS SER ASP LEU SER PHE SER SEQRES 5 F 94 LYS ASP TRP SER PHE TYR LEU LEU TYR TYR THR GLU PHE SEQRES 6 F 94 THR PRO THR GLU LYS ASP GLU TYR ALA CYS ARG VAL ASN SEQRES 7 F 94 HIS VAL THR LEU SER GLN PRO LYS ILE VAL LYS TRP ASP SEQRES 8 F 94 ARG ASP MET SEQRES 1 G 94 MET ILE GLN VAL TYR SER ARG HIS PRO ALA GLU ASN GLY SEQRES 2 G 94 LYS SER ASN PHE LEU ASN CYS TYR VAL SER GLY PHE HIS SEQRES 3 G 94 PRO SER ASP ILE GLU VAL ASP LEU LEU LYS ASN GLY GLU SEQRES 4 G 94 ARG ILE GLU LYS VAL GLU HIS SER ASP LEU SER PHE SER SEQRES 5 G 94 LYS ASP TRP SER PHE TYR LEU LEU TYR TYR THR GLU PHE SEQRES 6 G 94 THR PRO THR GLU LYS ASP GLU TYR ALA CYS ARG VAL ASN SEQRES 7 G 94 HIS VAL THR LEU SER GLN PRO LYS ILE VAL LYS TRP ASP SEQRES 8 G 94 ARG ASP MET FORMUL 8 HOH *295(H2 O) HELIX 1 1 TYR A 27 ARG A 31 5 5 HELIX 2 2 GLU A 87 THR A 91 5 5 HELIX 3 3 ILE A 100 ARG A 105 1 6 HELIX 4 4 TYR B 27 ARG B 31 5 5 HELIX 5 5 GLU B 87 THR B 91 5 5 HELIX 6 6 ILE B 100 ARG B 105 1 6 HELIX 7 7 TYR C 27 ARG C 31 5 5 HELIX 8 8 GLU C 87 THR C 91 5 5 HELIX 9 9 ILE C 100 ARG C 105 1 6 HELIX 10 10 HIS D 31 SER D 33 5 3 HELIX 11 11 HIS E 31 SER E 33 5 3 HELIX 12 12 HIS F 31 SER F 33 5 3 SHEET 1 AA 4 GLN A 3 SER A 7 0 SHEET 2 AA 4 LEU A 18 SER A 25 -1 O SER A 21 N SER A 7 SHEET 3 AA 4 VAL A 79 MET A 83 -1 O VAL A 79 N CYS A 22 SHEET 4 AA 4 PHE A 68 SER A 71 -1 O THR A 69 N GLN A 82 SHEET 1 AB 4 SER A 11 GLN A 13 0 SHEET 2 AB 4 THR A 122 SER A 127 1 O THR A 125 N VAL A 12 SHEET 3 AB 4 ALA A 92 ASP A 99 -1 O ALA A 92 N VAL A 124 SHEET 4 AB 4 TYR A 117 TRP A 118 -1 O TYR A 117 N THR A 98 SHEET 1 AC 6 SER A 11 GLN A 13 0 SHEET 2 AC 6 THR A 122 SER A 127 1 O THR A 125 N VAL A 12 SHEET 3 AC 6 ALA A 92 ASP A 99 -1 O ALA A 92 N VAL A 124 SHEET 4 AC 6 CYS A 33 GLN A 39 -1 O CYS A 33 N ASP A 99 SHEET 5 AC 6 GLU A 46 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AC 6 THR A 58 TYR A 60 -1 O TYR A 59 N ARG A 50 SHEET 1 AD 2 TYR A 117 TRP A 118 0 SHEET 2 AD 2 ALA A 92 ASP A 99 -1 O THR A 98 N TYR A 117 SHEET 1 BA 4 GLN B 3 SER B 7 0 SHEET 2 BA 4 LEU B 18 SER B 25 -1 O SER B 21 N SER B 7 SHEET 3 BA 4 VAL B 79 MET B 83 -1 O VAL B 79 N CYS B 22 SHEET 4 BA 4 PHE B 68 GLN B 72 -1 O THR B 69 N GLN B 82 SHEET 1 BB 4 SER B 11 GLN B 13 0 SHEET 2 BB 4 THR B 122 SER B 127 1 O THR B 125 N VAL B 12 SHEET 3 BB 4 ALA B 92 ASP B 99 -1 O ALA B 92 N VAL B 124 SHEET 4 BB 4 TYR B 117 TRP B 118 -1 O TYR B 117 N THR B 98 SHEET 1 BC 6 SER B 11 GLN B 13 0 SHEET 2 BC 6 THR B 122 SER B 127 1 O THR B 125 N VAL B 12 SHEET 3 BC 6 ALA B 92 ASP B 99 -1 O ALA B 92 N VAL B 124 SHEET 4 BC 6 CYS B 33 GLN B 39 -1 O CYS B 33 N ASP B 99 SHEET 5 BC 6 GLU B 46 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 BC 6 THR B 58 TYR B 60 -1 O TYR B 59 N ARG B 50 SHEET 1 BD 2 TYR B 117 TRP B 118 0 SHEET 2 BD 2 ALA B 92 ASP B 99 -1 O THR B 98 N TYR B 117 SHEET 1 CA 4 GLN C 3 SER C 7 0 SHEET 2 CA 4 LEU C 18 SER C 25 -1 O SER C 21 N SER C 7 SHEET 3 CA 4 VAL C 79 MET C 83 -1 O VAL C 79 N CYS C 22 SHEET 4 CA 4 PHE C 68 SER C 71 -1 O THR C 69 N GLN C 82 SHEET 1 CB 4 GLY C 10 GLN C 13 0 SHEET 2 CB 4 THR C 122 SER C 127 1 O GLN C 123 N GLY C 10 SHEET 3 CB 4 ALA C 92 ASP C 99 -1 O ALA C 92 N VAL C 124 SHEET 4 CB 4 TYR C 117 TRP C 118 -1 O TYR C 117 N THR C 98 SHEET 1 CC 6 GLY C 10 GLN C 13 0 SHEET 2 CC 6 THR C 122 SER C 127 1 O GLN C 123 N GLY C 10 SHEET 3 CC 6 ALA C 92 ASP C 99 -1 O ALA C 92 N VAL C 124 SHEET 4 CC 6 CYS C 33 GLN C 39 -1 O CYS C 33 N ASP C 99 SHEET 5 CC 6 ARG C 45 ILE C 51 -1 O GLU C 46 N ARG C 38 SHEET 6 CC 6 THR C 58 TYR C 60 -1 O TYR C 59 N ARG C 50 SHEET 1 CD 2 TYR C 117 TRP C 118 0 SHEET 2 CD 2 ALA C 92 ASP C 99 -1 O THR C 98 N TYR C 117 SHEET 1 DA 4 ILE D 7 SER D 11 0 SHEET 2 DA 4 ASN D 21 SER D 28 -1 O ASN D 24 N TYR D 10 SHEET 3 DA 4 PHE D 62 PHE D 70 -1 O LEU D 64 N VAL D 27 SHEET 4 DA 4 SER D 55 PHE D 56 1 O SER D 55 N TYR D 63 SHEET 1 DB 4 ILE D 7 SER D 11 0 SHEET 2 DB 4 ASN D 21 SER D 28 -1 O ASN D 24 N TYR D 10 SHEET 3 DB 4 PHE D 62 PHE D 70 -1 O LEU D 64 N VAL D 27 SHEET 4 DB 4 GLU D 50 HIS D 51 -1 O GLU D 50 N TYR D 67 SHEET 1 DC 2 SER D 55 PHE D 56 0 SHEET 2 DC 2 PHE D 62 PHE D 70 1 O TYR D 63 N SER D 55 SHEET 1 DD 6 GLU D 44 ARG D 45 0 SHEET 2 DD 6 ILE D 35 LYS D 41 -1 O LYS D 41 N GLU D 44 SHEET 3 DD 6 TYR D 78 LYS D 94 -1 O ALA D 79 N LEU D 40 SHEET 4 DD 6 TYR E 78 LYS E 94 -1 O CYS E 80 N VAL D 93 SHEET 5 DD 6 ILE E 35 LYS E 41 -1 O GLU E 36 N ASN E 83 SHEET 6 DD 6 GLU E 44 ARG E 45 -1 O GLU E 44 N LYS E 41 SHEET 1 EA 4 ILE E 7 SER E 11 0 SHEET 2 EA 4 ASN E 21 SER E 28 -1 O ASN E 24 N TYR E 10 SHEET 3 EA 4 TYR E 63 PHE E 70 -1 O LEU E 64 N VAL E 27 SHEET 4 EA 4 GLU E 50 ASP E 53 -1 O GLU E 50 N TYR E 67 SHEET 1 FA 4 ILE F 7 SER F 11 0 SHEET 2 FA 4 ASN F 21 SER F 28 -1 O ASN F 24 N TYR F 10 SHEET 3 FA 4 TYR F 63 PHE F 70 -1 O LEU F 64 N VAL F 27 SHEET 4 FA 4 GLU F 50 ASP F 53 -1 O GLU F 50 N TYR F 67 SHEET 1 FB 6 GLU F 44 ARG F 45 0 SHEET 2 FB 6 ILE F 35 LYS F 41 -1 O LYS F 41 N GLU F 44 SHEET 3 FB 6 TYR F 78 LYS F 94 -1 O ALA F 79 N LEU F 40 SHEET 4 FB 6 TYR G 78 LYS G 94 -1 O CYS G 80 N VAL F 93 SHEET 5 FB 6 ILE G 35 LYS G 41 -1 O GLU G 36 N ASN G 83 SHEET 6 FB 6 GLU G 44 ARG G 45 -1 O GLU G 44 N LYS G 41 SHEET 1 GA 4 ILE G 7 SER G 11 0 SHEET 2 GA 4 ASN G 21 SER G 28 -1 O ASN G 24 N TYR G 10 SHEET 3 GA 4 TYR G 63 PHE G 70 -1 O LEU G 64 N VAL G 27 SHEET 4 GA 4 GLU G 50 HIS G 51 -1 O GLU G 50 N TYR G 67 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.00 SSBOND 2 CYS A 33 CYS A 104 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 96 1555 1555 2.02 SSBOND 4 CYS B 33 CYS B 104 1555 1555 2.10 SSBOND 5 CYS C 22 CYS C 96 1555 1555 2.00 SSBOND 6 CYS C 33 CYS C 104 1555 1555 2.03 SSBOND 7 CYS D 25 CYS D 80 1555 1555 2.00 SSBOND 8 CYS E 25 CYS E 80 1555 1555 1.95 SSBOND 9 CYS F 25 CYS F 80 1555 1555 1.96 SSBOND 10 CYS G 25 CYS G 80 1555 1555 1.99 CISPEP 1 GLY B 8 GLY B 9 0 15.34 CISPEP 2 ASN B 74 ALA B 75 0 3.82 CISPEP 3 ASN C 74 ALA C 75 0 5.34 CISPEP 4 ALA C 75 LYS C 76 0 16.84 CISPEP 5 TRP F 60 SER F 61 0 -14.41 CRYST1 77.490 100.864 83.743 90.00 106.43 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012905 0.000000 0.003805 0.00000 SCALE2 0.000000 0.009914 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012450 0.00000